Aclaris Therapeutics (ACRS) said late Friday it was included in the Nasdaq Biotechnology Index, effective immediately.
The index is evaluated yearly and is calculated under a modified capitalization-weighted methodology.
Aclaris Therapeutics (ACRS) said late Friday it was included in the Nasdaq Biotechnology Index, effective immediately.
The index is evaluated yearly and is calculated under a modified capitalization-weighted methodology.
Comments